Not a healthcare professional? Go to the patient or caregiver website.

ZINECARD®Indications and Usage (dexrazoxane)

1 INDICATIONS AND USAGE

ZINECARD is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m2 and who will continue to receive doxorubicin therapy to maintain tumor control. Do not use with the initiation of doxorubicin therapy [see Warnings and Precautions (5.2)].

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No